General form of registration statement for all companies including face-amount certificate companies

Stockholders' (Deficit) Equity - Addtional Information (Details)

v3.23.3
Stockholders' (Deficit) Equity - Addtional Information (Details)
 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 19, 2023
USD ($)
Jul. 18, 2023
Jun. 29, 2023
Apr. 19, 2023
USD ($)
$ / shares
shares
Jun. 29, 2022
Dec. 10, 2021
USD ($)
$ / shares
shares
Oct. 28, 2021
USD ($)
$ / shares
shares
Sep. 02, 2021
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2022
shares
 [1]
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
shares
 [1]
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Subsidiary, Sale of Stock [Line Items]                            
Forward split ratio     0.25   0.25     4.55821     0.25   0.25  
Proceeds from initial public offering                           $ 25,378,663
Net proceeds from offering             $ 24,547,086       $ 6,431,615      
Warrants to purchase common shares | shares           56,250                
Warrants exercise price | $ / shares           $ 16     $ 5   $ 5      
Proceeds from warrant exercises           $ 900,000               $ 900,000
Price per share | $ / shares       $ 4                 $ 16  
Debt Seller | Maestro Health LLC                            
Subsidiary, Sale of Stock [Line Items]                            
Percentage of payment on net proceeds of offering until such time as purchase price paid in full       35.00%                    
Payment on net proceeds of offering until such time as purchase price paid in full       $ 2,294,751                    
Debt Seller | Maestro Health LLC | Subsequent Event                            
Subsidiary, Sale of Stock [Line Items]                            
Percentage of payment on net proceeds of offering due amount as purchase price to be paid   50.00%                        
Payment on net proceeds of offering due amount as purchase price to be paid $ 1,147,376                          
Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued | shares                 1,850,000 [1]   1,850,000 [1]     2,786,826 [2]
Shares issued to vendors in exchange for services (in shares) | shares                   5,625 25,000 [1] 5,625 9,375  
Initial Public Offering                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued | shares             1,562,500              
Proceeds from initial public offering             $ 28,750,000              
Share price | $ / shares             $ 16              
Over Allotment                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued | shares             234,375              
Public Offering                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares issued | shares       1,850,000                    
Net proceeds from offering       $ 6,400,000                    
Price per share | $ / shares       $ 4                    
Gross proceeds from offering       $ 7,400,000                    
[1] Reflects 1-for-4 reverse stock split that became effective June 29, 2023. See Note 1 to the unaudited condensed consolidated financial statements.
[2] Reflects 1-for-4 reverse stock split that became effective June 29, 2022. See Note 3 to the consolidated financial statements.